DIA会员及用户请点击登录

登录

忘记用户 ID? or 忘记密码?

Not a Member?

创建账户并加入。

Hilton Lac-Leamy

2024 年 11 月 14 日 7:30 上午 - 2024 年 11 月 15 日 4:10 下午

3 Boulevard du Casino, Gatineau, QC J8Y 6X4, Canada

Canada Annual Meeting

The Canada Annual Meeting offers three tracks, Regulatory, Clinical, Safety and Pharmacovigilance!

Early Bird Rates Expire

DAYS

HOURS

MINUTES

SECONDS

亮点与特色

What is happening at Canada Annual Meeting

Need Approval in Order to Attend?

Download and fill out our Justification Letter to demonstrate to your supervisor why this is a must-attend event.


  • Discuss policy updates and priorities shared directly from Health Canada
  • Stay up to date with emerging trends and technologies effecting life sciences professionals in Canada
  • Establish and foster relationships with life sciences professionals in Canada
  • Gain additional insights, education, and knowledge to analyze relevant challenges and opportunities for life sciences professionals in Canada


• Three educational tracks: Regulatory, Clinical, Safety and Pharmacovigilance


Track 1: Regulatory

The regulatory track provides opportunities for information sharing, use cases, and best practices relating to Canada’s regulatory landscape as it applies to regulatory requirements, new developments, and innovation for life sciences R&D.

Track 2: Clinical

Today, modern pharmaceutical, medical device, and diagnostic products are advancing at an unprecedented speed. Sessions in this track will focus on clinical research development and operations for industry. Those interested in this track will gain an understanding of Health Canada’s approach to the modernization of clinical trial regulations and gain further perspectives from patients and those in the life sciences R&D industry.

Track 3: Safety and Pharmacovigilance

Our safety and pharmacovigilance track will provide a comprehensive overview of Canada’s regulatory environment in the field of clinical safety and pharmacovigilance for pharmaceutical products and medical devices.

获得信息并保持参与

不要错失任何机会——请加入我们的邮件列表,了解DIA的观点和事件。